⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
CATX News
Perspective Therapeutics, Inc.
Perspective Therapeutics Announces Acceptance of VMT-α-NET Data for Presentation at the 38th EORTC-NCI-AACR Symposium 2026
globenewswire.com
CATX
Form 8-K
sec.gov
CATX
Form 8-K
sec.gov
CATX
Perspective Therapeutics Provides Recent Business Highlights and Reports 2Q 2026 Results
globenewswire.com
CATX
Form 8-K
sec.gov
CATX
Perspective Therapeutics to Provide Business Highlights and Report Second Quarter 2026 Financial Results
globenewswire.com
CATX
Perspective Therapeutics Receives European Orphan Medicinal Product Designation for [212Pb]VMT-α-NET in GEP-NETs
globenewswire.com
CATX
Perspective Therapeutics Announces Acceptance of VMT-α-NET Data for Oral Presentation at the ESMO Congress 2026
globenewswire.com
CATX
Perspective Therapeutics Appoints Paul Lyne, Ph.D., as Chief Science Officer; Co-Founder Michael K. Schultz, Ph.D., Transitions to Senior Scientific Advisor
globenewswire.com
CATX
Form 8-K
sec.gov
CATX